It's our goal to help you uncover evidence that delivers the greatest impact for your product. Xcenda implements innovative and creative approaches to projects while still stringently adhering to good clinical practices, FDA regulations, and international standards. With a more streamlined protocol and focus on only the most relevant patient recruitment sources, we’re able to get the most for your real-world evidence investment with greater cost efficiencies and quicker results.
Why Xcenda for your Prospective Studies needs?
Faster Patient Recruitment
Average time for first patient enrolled = Under 4 months
Increased Patient Retention
Patient retention = 50% Improvement compared to industry average
Experience You Can Trust
Average years of clinical study experience per team member = 15 Years
Support your value story with innovative real-world evidence approaches.
Real-world evidence (RWE) has become a veritable necessity for continued commercial success. The 21st Century Cures Act, passed in 2016, places additional focus on the use of real-world data to support regulatory decision-making, including both drug approvals and new indications for approved drugs. Knowing the value of RWE is one thing. But how do manufacturers realistically gather—and integrate—data that supports their product value story, both pre-and post-launch?
Meet the Expert
Kim McLeod, MPH
